ORAL PRESENTATION SESSION

You will find below the Oral Presentation Sessions scheduled for GAP 2016 and the approved abstracts for that sessions. Authors will have 10 minutes to make their presentation and 05 to questions and answers from the audience.

We kindly ask authors to use the GAP 2016 PPT template to prepare your presentation. Presenter authors must download your presentations at the Media Desk (at Renaissance Hotel) at least 1 hour prior the session. Will not be allowed presenters to use your own computer.

All the abstracts presentations will take place at Renaissance Hotel, in São Paulo.

ORAL PRESENTATION SESSIONS – SCIENTIFIC PROGRAM
APRIL 26TH, 2016

Colorectal Cancers Session
Time: 02:00pm – 03:15pm / Room: Labrador – Abstracts:

186

EVALUATION OF RKIP EXPRESSION AND KRAS/BRAF MUTATIONAL PROFILE OF ANAL TUMORS

419

OUTCOME OF INITIAL SCREENING FOR LYNCH SYNDROME IN CHINESE PATIENTS WITH COLORECTAL CANCER

315

COORDINATED MINIMALLY-INVASIVE MULTI-STAGE SURGERY FOR STAGE IV COLORECTAL CANCER

484

SEARCHING FOR NEW CANDIDATES GENES IN PATIENTS SUSPECTED OF LYNCH SYNDROME

98

ABERRANT ACTIVATION OF USP22 IS CRITICAL IN COLORECTAL CANCER PROGRESSION


Genitourinary Cancers Session

Time: 02:00pm – 03:30pm / Room: Patagônia – Abstracts:

328 INTEGRATIVE METHODOLOGY TO UNCOVER DRIVERS CANDIDATES ASSESSING GENOMIC, TRANSCRIPTOMIC, MIRNA AND METHYLATION DATA IN PENILE CARCINOMA.

616

THE CLINICOPATHOLOGICAL SIGNIFICANCE OF MONOCARBOXYLATE TRANSPORTERS (MCTS) IN GERM CELL TUMORS

606

CLINICAL SIGNIFICANCE OF PD-L1 PROTEIN EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN LOCALIZED BLADDER CANCER

65

REVISITING TUMOR ANGIOGENESIS: VESSEL CO-OPTION AND REMODELING

374

A RETROSPECTIVE COMPARATIVE STUDY OF SODIUM FLUORIDE (NAF-18)-PET/CT AND FLUOROCHOLINE (F-18-CH) PET/CT IN THE EVALUATION SKELETAL METASTASES IN METASTATIC PROSTATE CANCER USING A VOLUMETRIC 3-D ANALYSIS

108

CYBERKNIFE (CK) FOR PROSTATE CANCER PATIENTS – EARLY RESULTS OF 400 PATIENTS RADIOABLATION


Hematologic Diseases

Time: 02:00pm – 03:30pm / Room: Tucun – Abstracts:

453

PATHWAY ANALYSIS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS BY WHOLE EXOME SEQUENCING

580

WEIGHT GAIN DURING THE FIRST 10 DAYS POST TRANSPLANTATION IS A RISK FACTOR FOR MORTALITY IN BOTH AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION

37

MICRORNA-494 ACTIVATION OVERCOMES THE DRUG RESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS MEDIATED BY BONE MARROW STROMAL CELLS

294

IDENTIFICATION OF A NOVEL MECHANISM OF NPM1 CYTOPLASMIC LOCALIZATION IN ACUTE MYELOID LEUKEMIA: THE RECURRENT GENE FUSION NPM1–HAUS1

514

HEMORRHAGIC CYSTITIS CAUSED BY THE BK VIRUS DECREASES SURVIVAL POST-ALLOGENEIC STEM CELL TRANSPLANTATION

527

BLINATUMOMAB AS SOLE REINDUCTION AGENT FOR REFRACTORY PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA


Melanoma and Sarcoma

Time: 04:00pm – 05:00pm / Room: Labrador – Abstracts:

343

N‑ACETYL‑S‑(P‑CHLOROPHENYLCARBAMOYL) CYSTEINE, A NOVEL INHIBITOR OF THIOREDOXIN REDUCTASE, INDUCES MITOCHONDRIAL‑MEDIATED APOPTOSIS AND SUPPRESSES MIGRATION IN MELANOMA CELLS

524

IS PET-CT AN ACCURATE METHOD FOR THE DIFFERENTIAL DIAGNOSIS BETWEEN CHONDROMA AND CHONDROSARCOMA?

31

HYPERICIN INHIBITS MELANOMA BONE METASTASIS AND OSTEOLYSIS BY MODULATING THE TUMOR-BONE MICROENVIRONMENT

604

GUIDED SURGERY BY INFRARED LIGHT FOR SENTINEL LYMPH NODE LOCALIZATION IN CUTANEOUS MELANOMA


Breast Session 1
Time: 04:00pm – 06:00pm / Room: Patagônia – Abstracts:

41

RECEPTOR CONVERSION AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

117

FOXK2: A NOVEL ONCOGENE THAT IS AMPLIFIED AND OVER-EXPRESSED IN BREAST CANCER

30

PROGNOSTIC SIGNIFICANCE OF THE PRETREATMENT PLATELET TO LYMPHOCYTE RATIO IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER

115

A PROGNOSTIC SIGNATURE BASED ON THREE-GENES EXPRESSION IN TRIPLE-NEGATIVE BREAST TUMOURS WITH RESIDUAL DISEASE

372

A MULTIDISCIPLINARY TEAM APPROACH TO EFFICIENT BREAST CANCER DIAGNOSIS

359

HER2-POSITIVE BREAST CANCER: IMPACT OF TARGET THERAPY ON SURVIVAL OF HISPANIC COHORT

46

TRANSLATOMICS IN INVASIVE BREAST CANCER: A BETTER COMPREHENSION FROM A TRANSLATION CONTROL PERSPECTIVE.


Gastrointestinal Session

Time: 04:00pm – 06:00 pm / Room: Tucun – Abstracts:

88

Signet ring cell carcinoma of the Esophagus: A SEER Database Analysis

140

Genomic features of Patient-Derived Xenografts of gastric cancer and transformation to lymphoma during its establishment

491

Evaluation of H pylori in Peruvian gastric cancer through RT- PCR

215

Prognostic and predict value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection

82

Large solitary hepatocellular carcinomas treated with transarterial chemoembolization: in which BCLC stage patients should be allocated?

86

Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value

64

WNT Signaling Promotes Gastric Tumorigenesis by Galectin-3 Mediated Activation of STAT3 Pathway

510

MPZL1 promotes gastric cancer metastasis and chemoresistance through PARP1 and CHK2 signalings

APRIL 27TH, 2016

Personalized Medicine Session
Time: 10:40am – 12:10pm / Room: Tucun – Abstracts:

653

NK CELL THERAPY OF CANCER: ENHANCING FUNCTION BY HYPOXIC EDUCATION

85

IMPLEMANTATION OF A NEXT-GENERATION SEQUENCING-BASED GENE PANEL (ONCOPRIME) TO CANCER PATIENTS IN JAPAN

156

SIMPLIFIED INTERVENTIONAL MAPPING SYSTEM (SIMS): A NOVEL MULTIPLEX COMBINATORIAL COMPANION TEST AND STRATEGY TO MATCH PATIENT TO SINGLE DRUGS AND COMBINATIONS OF DRUGS

334

DETECTION OF ALK FUSION TRANSCRIPTS IN FFPE BRAZILIAN LUNG CANCER SAMPLES BY NANOSTRING TECHNOLOGY

505

COMPREHENSIVE GENOMIC PROFILING OF DESMOPLASTIC SMALL ROUND CELL TUMOR

619

KAPOSIFORM HEMANGIOENDOTHELIOMA: COULD SIROLIMUS REPLACE VINCRISTINE AS THE FIRST-CHOICE TREATMENT?


Liquid Biopsy – Prognostic and Treatment Response Session

Time: 02:00pm – 03:30pm / Room: Yukun – Abstracts:

585

EXPRESSION OF MRP-2 IN CIRCULATING TUMOR CELLS (CTCS) OF PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LAHNSCC) AND THEIR RELATION WITH PROGRESSION FREE SURVIVAL.

317

A PROSPECTIVE STUDY OF CIRCULATING TUMOR CELLS IN PATIENTS WITH RECTAL CANCER

649

PRION PROTEIN REGULATES THE SECRETION OF EXOSOMES MODULATING CAVEOLIN-1-SUPPRESSED AUTOPHAGY

584

EXPRESSION OF TGF-Β IN CIRCULATING TUMOR CELLS (CTCS) OF PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LAHNSCC) AND THEIR RELATION WITH PROGRESSION FREE SURVIVAL.

439

LIQUID BIOPSY FOR MONITORING CHEMOTHERAPY RESPONSE IN WILMS TUMOR PATIENTS: SOMATIC TUMOR MUTATIONS IN URINE DNA BEFORE AND AFTER TREATMENT.

323

EVALUATION OF CIRCULATING TUMORAL MICROEMBOLI (CTM) AS A PROGNOSTIC FACTOR IN METASTATIC COLORECTAL CANCER PATIENTS


Hereditary tumors Session

Time: 02:00pm – 02:45pm / Room: Labrador – Abstracts:

370

GERMLINE BRCA1 AND BRCA2 MUTATIONS IN HIGH-RISK PATIENTS IN MEDELLIN, COLOMBIA

316

COMPLETION OF FOLLOW-UP AFTER ABNORMAL SCREENING TEST FOR LYNCH SYNDROME: A FRAMEWORK FOR MULTI-LEVEL CANCER CARE DELIVERY

630

COMPARATIVE ANALYSIS OF VARIANT OF UNCERTAIN SIGNIFICANCE IN BRCA1 AND BRCA2 AMONGST FOUR INSTITUTIONS


Radiation Oncology Session

Time: 2:00pm – 3:30pm / Room: Tucun – Abstracts:

58

DEVELOPING HYPERBRANCHED POLYGLYCEROL-BASED NANOPARTICLES FOR TARGETED DELIVERY OF RADIOSENSITIZERS

121

TRANSCRIPTOMIC CHANGES DURING CARBON ION RADIOTHERAPY OF PROSTATE CANCER PATIENTS DETECTED BY RNA-SEQ

132

UNI-INSTITUTIONAL LONG TERM RESULTS OF HIGH DOSE RATE BRACHYTHERAPY COMBINED TO EXTERNAL BEAM RADIOTHERAPY FOR LOCAL AND LOCALLY ADVANCED PROSTATE CANCER

266

THE CORRELATION BETWEEN AEG-1 EXPRESSION AND RADIO-SENSITIVITY AND PROGNOSIS IN NON-SMALL CELL LUNG CANCER

498

RADIOTHERAPY IN THE TREATMENT OF CHORDOMA.

558

COMPUTER-BASED INTRA AND INTER-OBSERVER SEGMENTATION CORRELATION FOR BRAIN METASTASIS: EVALUATION OF POTENTIAL SYSTEMATIC ERROR IMPROVEMENT.


Gynecologic Cancers Session

Time: 4:00pm – 5:45pm / Room: Tucun – Abstracts:

287

PROGNOSTIC VALUE OF IMMUNOPHENOTYPING LYMPHOID SUBPOPULATIONS IN INVASIVE VULVA CARCINOMA

136

BINDING OF GALECTIN-1 TO CA125 PROMOTED TUMOR INVASION AND PROGRESSION IN OVARIAN CANCER

406

LOCOREGIONAL RECURRENCE OF GYNECOLOGIC CANCER: WHAT IS THE ROLE OF MRI?

565

PUTATIVE MIRNAS REGULATORS OF HMGA2 IN UTERINE LEIOMYOMAS AND ITS ASSOCIATION WITH MED12 MUTATION

296

ABLATION TECHNIQUES ADAPTED FOR LOW- AND MIDDLE-INCOME COUNTRIES

279

MIDAS: A PRACTICAL BAYESIAN DESIGN FOR PLATFORM TRIALS WITH IMMUNOTHERAPY AGENTS

427

AN EVALUATION OF NFKB EXPRESSION PROTEIN IN PATIENTS WITH OVARIAN SEROUS CARCINOMA IN NON-SENSITIVE GROUP TO CHEMOTHERAPY.


Diagnostic Imaging Session

Time: 4:00pm – 6:00pm / Room: Labrador – Abstracts:

148

RADIOEMBOLIZATION OF PRIMARY AND SECONDARY HEPATIC MALIGNANCIES

376

EVALUATION OF OSTEOSARCOMA RESPONSE TO RADIUM-223 TREATMENT USING BONE SCINTIGRAPHY, NAF-PET, AND FDG-PET

152

PREDICTIVE EFFICACY OF 11C-PD153035 PET IMAGING FOR EGFR–TYROSINE KINASE INHIBITOR SENSITIVITY IN NON-SMALL CELL LUNG CANCER PATIENTS

143

DESCRIPTION AND CLINICAL IMPLICATIONS OF INCIDENTALLY-FOUND LESIONS ON CONE-BEAM CT ANGIOGRAPHY DURING TACE/TAE IN PATIENTS WITH METASTATIC TUMORS

660

DOES REDUCED FIELD OF VIEW DIFFUSION SEQUENCE HAS THE ABILITY IN ASSESSING MICROSATELLITE INSTABILITY? AN INITIAL EXPERIENCE

626

QUANTITATIVE IMAGING OF THORACIC MALIGNANCIES

425

INFLUENCE OF FASTING ON CONTRAST-ENHANCED CT SCANS IN A CANCER CENTER.

560

DOES PATHOLOGICAL FEATURES AFFECTS THE AGREEMENT BETWEEN MRI AND PATHOLOGIC TUMOR SIZE ON INVASIVE BREAST CARCINOMAS?


Lung Session

Time: 4:00pm – 6:00pm /Room: Patagônia – Abstracts:

49

REQUIREMENTS AND IMPLEMENTATION OF LUNG SBRT PROGRAM IN DEVELOPING COUNTRIES : BENEFIT OF INTERNATIONAL COOPERATION MDACC & KHCC AS AN EXAMPLE

155

CLINICAL EVALUATION OF AN IMPROVED METHOD FOR EPIDERMAL GROWTH FACTOR RECEPTORMUTATION DETECTION

302

CORRELATION OF NEUROENDOCRINE DIFFERENTIATION FEATURES WITH PROGNOSIS OF NON SMALL CELL LUNG CANCER IN CHINESE POPULATION

494

THE IMPORTANCE OF THORACIC RADIOTHERAPY AND RADIATION DOSE ON THE PROGNOSIS OF EXTENSIVE STAGE SMALL CELL LUNG CANCER

536

ABSTRACT MINIMALLY INVASIVE SURGICAL STRATEGIES IN THE FIRST BRAZILIAN LUNG CANCER SCREENING TRIAL (BRET1)

555

LUNG CANCER SCREENING IN THE US

623

BUILDING A LUNG CT SCREENING PROGRAM AS A MODEL FOR RESEARCH,EDUCATION AND HEALTH CARE

456

VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS) PULMONARY WEDGE RESECTION WITHOUT POST-OPERATIVE CHEST DRAIN

APRIL 28TH, 2016

Population Science & Cancer Epidemiology Session
Time: 10:40am – 12:55pm / Room: Labrador – Abstracts:

367

BUILDING CAPACITY FOR CANCER CONTROL: THE GLOBAL INITIATIVE FOR CANCER REGISTRY DEVELOPMENT

500

HISTORICAL ANALYSIS OF THE BRAZILIAN CERVICAL CANCER SCREENING PROGRAM FROM 2006 TO 2013: A TIME FOR REFLECTION

602

SIGNIFICANT DIFFERENCES IN DEMOGRAPHIC AND CLINICOPATHOLOGICAL CHARACTERISTICS BETWEEN PATIENTS WITH BLADDER CANCER FROM AN ARSENIC-EXPOSED REGION AND FROM TWO REFERENCE SITES: A COMPARATIVE STUDY

189

TRENDS IN LOCAL THERAPY UTILIZATION AND COST FOR EARLY-STAGE BREAST CANCER IN OLDER AMERICAN WOMEN: IMPLICATIONS FOR POPULATION HEALTH MANAGEMENT

87

IMPACT OF MARITAL STATUS ON SURVIVAL OF GASTRIC ADENOCARCINOMA PATIENTS: RESULTS FROM THE SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER) DATABASE.

101

FATIGUE, QUALITY OF LIFE AND RELATED SYMPTOMS: PATIENT REPORTED OUTCOMES IN MYELODYSPLASTIC SYNDROME

434

LEUKOCYTE TELOMERE LENGTH AND PROGNOSIS OF LOCALIZED PROSTATE CANCER

454

GLOBAL AND GENE-SPECIFIC PROMOTER METHYLATION CHANGES AND MICRONUCLEI LEVELS IN CONSTRUCTION WORKERS EXPOSED TO ENVIRONMENTAL CARCINOGENS

391

BIOBANK ACCESS POLICY THAT BOOSTS THE CANCER CENTER BIOSAMPLE USAGE AND ELEVATES THE INSTITUTIONAL RESEARCH LEVEL


Survivorship Session

Time: 10:40am – 12:10pm / Room: Patagônia – Abstracts:

165

HOW WILL CANCER SURVIVORS USE SURVIVORSHIP CARE PLANS (SCPS)?

277

TOBACCO USE AMONG LYMPHOMA SURVIVORS

278

USING CLINICAL ALGORITHMS TO IDENTIFY PSYCHOSOCIAL DISTRESS AND OTHER RISK FACTORS IN CANCER SURVIVORS

314

PRIMARY HEALTH CONCERNS PERCEIVED BY LONG-TERM DISEASE-FREE COLORECTAL CANCER SURVIVORS: A QUALITATIVE ANALYSIS

426

PRIMARY HEALTH CONCERNS PERCEIVED BY LONG-TERM DISEASE-FREE COLORECTAL CANCER SURVIVORS: A QUALITATIVE ANALYSIS

525

IMAGING STUDIES DURING SURVIVORSHIP AFTER LYMPHOMA TREATED WITH CURATIVE INTENT


Ovarian Session

Time: 12:10pm – 12:55pm / Room: Patagônia – Abstracts:

150

IDENTIFICATION OF CANDIDATE GENES FOR GRANULOSA CELL TUMOR PROGRESSION

211

MIR-211 REGULATES OVARIAN CANCER MALIGNANCY BY TARGETING CYCLIN D1 AND CDK6

435

DOWN-REGULATED EXPRESSION OF MICRORNAS IN HIGH GRADE SEROUS OVARIAN CANCER OF PATIENTS WITH DIFFERENT CLINICAL OUTCOMES


Neuro Oncology Session

Time: 10:40am – 12:55pm / Room: Andes – Abstracts:

337

THE SURGEON MAY BE AIDED IN THE DELICATE ONCO-FUNTIONAL BALANCE IN RESECTION OF MALIGNANT GLIOMAS BY THE COMBINED USE OF 5-ALA AND AWAKE CRANIOTOMY WITH CORTICAL AND SUBCORTICAL MAPPIPING

112

ESTABLISHING THE ROLE OF ARGININE DEPRIVATION IN CANCER TREATMENT THROUGH PRE-CLINICAL ACTIVITY OF THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN GLIOMAS AND SOFT-TISSUE SARCOMAS (STS)

204

QKI DELETION ENHANCES SELF-RENEWAL OF GLIOMA STEM CELLS AND PROMOTES GLIOMAGENESIS

207

C-FOS OVER-EXPRESSION PROMOTES RADIORESISTANCE AND PREDICTS POOR PROGNOSIS IN MALIGNANT GLIOMA

71

TREATMENT OF RECURRENT MALIGNANT GLIOMA WITH BCNU-LOADED BIODEGRADABLE IMPLANTS: EXPERIENCE OF 22 CHINESE CASES

96

OVEREXPRESSION OF TEAD4 IN AT/RT; NEW INSIGHT TO THE PATHOPHYSIOLOGY OF AN AGGRESSIVE BRAIN TUMOR

145

Β-ELEMENE INDUCES CASPASE-DEPENDENT APOPTOSIS IN HUMAN GLIOMA CELLS IN VITRO THROUGH THE UPREGULATION OF BAX AND FAS/FASL AND DOWNREGULATION OF BCL-2

151

THERAPEUTIC EFFECTS OF THIADIAZOLE DERIVATIVES ON GLIOBLASTOMA CELL LINES.

455

COPY NUMBER PROFILING OF BRAZILIAN ASTROCYTOMAS


Anesthesiology Session

Time: 10:40am – 12:05am / Room: Yukun – Abstracts:

01

459

MULTIMODAL ANALGESIC TREATMENT IN VIDEO-ASSISTED THORACIC SURGERY LOBECTOMY USING AN INTRAOPERATIVE INTERCOSTAL CATHETER

02

73

A RETROSPECTIVE REVIEW OF FACTORS ASSOCIATED WITH CORNEAL ABRASIONS AFTER ONCOLOGIC SURGERY IN A TERTIARY CANCER CENTER

03

380

FUNCTIONALITY AND END-USER ACCEPTABILITY OF THE INTERNET-BASED COMPUTERIZED PATIENT ASSESSMENT SYSTEM (ICOMPASS), A MOBILE SYMPTOM MONITORING SYSTEM


Critical Care Session

Time: 12:05am – 12:50pm / Room: Yukun – Abstracts:

492

Oncologic emergencies

424

Intra abbdominal pressure monitoring admitted to the intensive care unit

645

Transfusion in older patients with cancer admitted to the intensive care unit


Cancer Prevention and early diagnosis

Time: 2:00pm – 3:30pm / Room: Yukun – Abstracts:

60

SCREENING AND EARLY DETECTION OF UTERINE CERVIX CANCERS USING VISUAL BASED SCREENING METHODS IN INDIA

528

CHANGING A NATIONAL CERVICAL CANCER SCREENING PROGRAM: RANDOMIZED IMPLEMENTATION OF PRIMARY HPV TESTING IN NORWAY

591

COLORECTAL CANCER SCREENING IN BARRETOS CANCER HOSPITAL, BRAZIL: INITIAL RESULTS FROM A PILOT IMPLEMENTATION PROGRAM

605

UNDERSTANDING ECONOMIES OF SCALE, SCOPE AND KNOWLEDGE AND THEIR IMPORTANCE TO SUCCESSFUL HEALTHCARE DELIVERY ORGANIZATIONS

56

“TELL ME EVERYTHING…ABOUT CANCER” COMMUNITY INTERVENTION TO CLARIFY MYTHS AND TRUTHS OF CANCER

262

SKIN CANCER SCREENING VIA TELEDERMATOLOGY: EXPERIENCE IN THE STATE OF SANTA CATARINA


Head & Neck Session

Time: 2:00pm – 3:30pm / Room: Labrador – Abstracts:

482

TREATMENT OF MAXILLOMANDIBULAR DEFECTS USING CUSTOM-MADE IMPLANTS WITH VASCULARIZED FIBULAR GRAFT

263

EXPERIENCE IN THE USE OF SENTINEL LYMPH NODE IN EARLY ORAL CANCER

51

PREDICTING THE SHORT-TERM RESPONSE TO CHEMORADIOTHERAPY USING INTRAVOXEL INCOHERENT MOTION DIFFUSION-WEIGHTED AND DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA

84

LONG-TERM OUTCOME OF LARYNGEAL FRAMEWORK RECONSTRUCTION USING TITANIUM MESH IN GLOTTIC CANCER AFTER FRONTOLATERAL VERTICAL PARTIAL LARYNGECTOMY

139

SIGNIFICANCE OF VOLUMETRIC STAGING AND MOLECULAR PROFILES IN RADIOTHERAPY FOR H&N CANCER

206

RELATIONSHIP BETWEEN POLYMORPHISMS IN GLUCOSE GLYCOLYTIC PATHWAY ASSOCIATED GENES AND RISK OF NASOPHARYNGEAL CARCINOMA DEVELOPMENT


Breast Session 2

Time: 2:00pm – 3:00pm / Room: América do Norte – Abstracts:

34

ANDROGEN RECEPTOR EXPRESSION PREDICTS DIFFERENT CLINICAL OUTCOMES FOR BREAST CANCER PATIENTS STRATIFIED BY HORMONE RECEPTOR STATUS.

149

ASTROCYTE-DERIVED EXOSOMAL MIR-19A REVERSIBLY DOWNREGULATES PTEN EXPRESSION IN CANCER CELLS TO PROMOTE BRAIN METASTASIS OUTGROWTH

120

STUDY ON DETECTION OF CIRCULATING TUMOR DNA IN BREAST CANCER

407

CHARACTERIZATION OF THE TRANSCRIPTIONAL LANDSCAPE OF CIRCULATING EXTRACELLULAR VESICLES IN HER-2+ BREAST CANCER PATIENTS